**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**



CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
  SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 24, 2009

**PFIZER INC.**
  (Exact name of registrant as specified in its charter)

|**Delaware**                                                                                       | **1-3619**               | **13-5315170**                      
|-------------------------------------------------------------------------------------------------- | ------------------------ | ------------------------------------
|(State or other Jurisdiction of incorporation)                                                     | (Commission File Number) | (I.R.S. Employer Identification No.)
|**235 East 42nd Street 
          New York, New York**(Address of principal executive offices)**** |                          | **10017**
        (Zip Code)        

> Registrant's telephone number, including area code:(212) 733-2323 ****Not Applicable	
>       (Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended
  to simultaneously satisfy the obligation of the registrant under any of the
  following provisions:

[   ] Written communication pursuant to Rule 425 under the Securities
  Act (17 CFR 230.425)

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange
  Act (17 CFR 240.14a-12)

[   ] Pre-commencement communications pursuant to Rule 14d-2(b)
  under the Exchange Act (17 CFR 240.14d-2(b))

[   ] Pre-commencement communications pursuant to Rule 13e-4(c)
  under the Exchange Act (17 CFR 240.13e-4(c))



|Item 5.02                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | **Departure of Directors or Certain Officers; Election  of Directors; Appointment of Certain Officers; Compensatory Arrangements of  Certain Officers**
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------
|On January 25, 2009, Pfizer Inc., a Delaware corporation  (the “Company”), Wyeth, a Delaware corporation, and Wagner Acquisition Corp., a  Delaware corporation and direct wholly owned subsidiary of Pfizer (“Merger Sub”), entered into an Agreement and Plan of  Merger (the “Merger Agreement”) whereby Merger  Sub would merge with and into Wyeth (the “Merger”)  with Wyeth surviving as a wholly owned subsidiary of the Company.  The Merger  Agreement provides that, upon completion of the Merger, the Company will  appoint to the Company board of directors two members of the Wyeth board of  directors who were members of the Wyeth board of directors as of the date of  the Merger Agreement.
      On  September 24, 2009, the Company board of directors expanded the size of the  board from 14 to 16 members. In addition, the Company board of directors  appointed Frances D. Fergusson and John P. Mascotte to serve as members of the  board, each to serve until the election and qualification of a successor or the  earlier death, resignation or removal of the director. Both the expansion of  the Company board of directors and the appointment of Frances D. Fergusson and  John P. Mascotte to the Company board of directors are subject to, and will  become effective upon, consummation of the Merger.  Frances D. Fergusson and John P. Mascotte will  receive compensation and be provided indemnification agreements as non-employee  directors in accordance with the Company's non-employee director compensation  practices described in the Company's Annual Proxy Statement filed with the  Securities and Exchange Commission on March 13, 2009.
      A copy of  the press release announcing the appointment of Frances D. Fergusson and John  P. Mascotte to the Company board of directors is attached hereto as Exhibit  99.1 and is incorporated by reference herein.



|**Item 9.01** | **Financial Statements and Exhibits.** | 
|------------- | -------------------------------------- | 

|(d) Exhibits |                                         | 
|------------ | --------------------------------------- | 
|             |                                         | 
|Exhibit No.  | Description                             | 
|99.1         | Press Release, dated September 25, 2009 | 





**SIGNATURE**

Under the requirements of the Securities Exchange Act of 1934, the registrant
  has caused this report to be signed on its behalf by the authorized undersigned.

|                          |  | PFIZER INC.                                                                                       
|------------------------- |  | --------------------------------------------------------------------------------------------------
|                          |  |                                                                                                   
|                          |  | By: /s/  Matthew Lepore
         Matthew Lepore                                                   
|                          |  | Title: Vice President, Chief Counsel - Corporate Governance,
        and Assistant General Counsel
|Dated: September 25, 2009 |  |                                                                                                   



> EXHIBIT INDEX

|Exhibit No. | Description                            
|----------- | ---------------------------------------
|99.1        | Press Release, dated September 25, 2009